Fact sheet: Fidelity Gbl Health Care

Fund information

Fund name
Fidelity Global Health Care W GBP
Fund company manager
Fidelity International (FIL In
Fund type
SIB
Fund manager
Alex Gold
since 30/06/2017
Fund objective
Aims to provide long-term capital growth with the level of income expected to be low. At least 70% invested in the shares of companies throughout the world that are involved in the design, manufacture, or sale of products and services used in health care, medicine or biotechnology. Has the freedom to invest outside the fund's principal geographies, market sectors, industries or asset classes. May invest in assets directly or achieve exposure indirectly through other eligible means including derivatives. Can use derivatives with the aim of risk or cost reduction or to generate additional capital or income, including for investment purposes, in line with the fund’s risk profile. The fund has discretion in its choices of investments within its objectives and policies. Income is reinvested in additional shares or paid to shareholders on request. Shares can usually be bought and sold each business day of the fund. This fund may not be appropriate for investors who plan to sell their shares in the fund within 5 years. Investment in the fund should be regarded as a long-term investment.
Benchmark
MSCI AC World Health Care
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

1.93 %

1 Year rank in sector

-

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 698.0 m

FE Risk score

119

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    65.6%
  • Denmark
    5%
  • Australia
    4.9%
  • China
    4.7%
  • France
    4.3%
  • Health Care
    96.3%
  • Consumer Discretionary
    2.2%
  • Money Market
    1.4%
  • Financials
    0.1%
  • US Equities
    65.6%
  • Danish Equities
    5%
  • Australian Equities
    4.9%
  • Chinese Equities
    4.7%
  • French Equities
    4.3%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-2.6 %-1.41 %1.93 %37.98 %109.8 %
Sector4.29 %4.59 %7.67 %20.6 %96.71 %
Rank within sector / / / / /
Quartile th th th th th th

Calendar performance

YTD-20172016201520142013
Fund5.72 %5 %13.1 %29.06 %30.73 %
Sector15.62 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector / / / / /
Quartile th th th th th th

Risk statistics

Alpha10.1
Beta0.58
Sharpe0.81
Volatility13.56
Tracking error12.45
Information ratio0.53
R-Squared0.43

Price movement

52 week high1.667
52 week low1.375
Current bid price0
Current offer price0
Current mid price1.533

Holdings by region

  • 65.6% USA
  • 5% Denmark
  • 4.9% Australia
  • 4.7% China
  • 4.3% France
  • 3.2% Switzerland
  • 2.9% Germany
  • 2.9% Japan
  • 2.2% UK
  • 1.8% Others

Holdings by sector

  • 96.3% Health Care
  • 2.2% Consumer Discretionary
  • 1.4% Money Market
  • 0.1% Financials

Holdings by asset type

  • 65.6% US Equities
  • 5% Danish Equities
  • 4.9% Australian Equities
  • 4.7% Chinese Equities
  • 4.3% French Equities
  • 3.2% Swiss Equities
  • 2.9% German Equities
  • 2.9% Japanese Equities
  • 2.2% UK Equities
  • 1.8% International Equities

Individual holdings

  • 9.1% JOHNSON & JOHNSON
  • 5.2% UNITEDHEALTH GROUP INC
  • 4.3% MERCK & CO INC(NEW)
  • 4.3% ROCHE HLDG AG
  • 4.2% MEDTRONIC INC
  • 3.9% ABBOTT LABORATORIES
  • 3.2% FRESENIUS MEDICAL CARE AG & CO.KGAA
  • 3.1% CSL
  • 2.8% NOVO NORDISK A/S
  • 2.7% LILLY (ELI) & CO